Business Description
HLB Pharmaceutical Co Ltd
ISIN : KR7047920004
Compare
Compare
Traded in other countries / regions
047920.Korea IPO Date
2015-12-21Description
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.25 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -3.96 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.22 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.9 | |||||
3-Year EBITDA Growth Rate | 75.8 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | -53.3 | |||||
3-Year Book Growth Rate | 11 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.99 | |||||
9-Day RSI | 38.88 | |||||
14-Day RSI | 38.43 | |||||
6-1 Month Momentum % | 147.16 | |||||
12-1 Month Momentum % | 102.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.1 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 1.01 | |||||
Days Inventory | 147.46 | |||||
Days Sales Outstanding | 52.46 | |||||
Days Payable | 58.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13 | |||||
Shareholder Yield % | 0.32 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.18 | |||||
Operating Margin % | -13.85 | |||||
Net Margin % | -15.87 | |||||
FCF Margin % | -13.69 | |||||
ROE % | -23.24 | |||||
ROA % | -14.71 | |||||
ROIC % | -16.16 | |||||
ROC (Joel Greenblatt) % | -15.06 | |||||
ROCE % | -9.61 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.36 | |||||
PB Ratio | 5.04 | |||||
Price-to-Tangible-Book | 5.26 | |||||
EV-to-EBIT | -64.24 | |||||
EV-to-EBITDA | -142.07 | |||||
EV-to-Revenue | 4.45 | |||||
EV-to-FCF | -32.49 | |||||
Price-to-Net-Current-Asset-Value | 18.61 | |||||
Earnings Yield (Greenblatt) % | -1.56 | |||||
FCF Yield % | -2.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 137,007.817 | ||
EPS (TTM) (â‚©) | -734 | ||
Beta | 1.2 | ||
Volatility % | 116.63 | ||
14-Day RSI | 38.43 | ||
14-Day ATR (â‚©) | 2351.829786 | ||
20-Day SMA (â‚©) | 22247 | ||
12-1 Month Momentum % | 102.12 | ||
52-Week Range (â‚©) | 11780 - 42050 | ||
Shares Outstanding (Mil) | 31.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HLB Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HLB Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
HLB Pharmaceutical Co Ltd Frequently Asked Questions
What is HLB Pharmaceutical Co Ltd(XKRX:047920)'s stock price today?
The current price of XKRX:047920 is â‚©19920.00. The 52 week high of XKRX:047920 is â‚©42050.00 and 52 week low is â‚©11780.00.
When is next earnings date of HLB Pharmaceutical Co Ltd(XKRX:047920)?
The next earnings date of HLB Pharmaceutical Co Ltd(XKRX:047920) is .
Does HLB Pharmaceutical Co Ltd(XKRX:047920) pay dividends? If so, how much?
HLB Pharmaceutical Co Ltd(XKRX:047920) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |